Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neurodiagnostic and Monitoring Devices Market by Product (Magnetoencephalography (MEG), Electromyography (EMG), Transcranial Cerebral Oximeters, Electroencephalogram (EEG), Cerebral Oximeters, Intracranial Pressure Monitor) and by End User (Operation Theatres, Hospitals, Clinics, Neurophysiological Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02270

Pages: NA

Charts: NA

Tables: NA

Neurodiagnostic and monitoring devices are used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinsons disease, and ischemic stroke. These devices include equipment such as CT scanner, MRI scanner, PET scanner, and others.

Major factors that drive the neurodiagnostic and monitoring devices market include increase in prevalence of neurological disorders, ability of the devices to monitor patients in ICUs, sleep monitoring, ease of portability, and low cost of the devices in comparison to the other medical imaging tools. However, lack of skilled workers and limitations of EEGs in providing accurate diagnosis may impede the market growth. Surge in incidence of neurological disorders, technological developments, and increase in healthcare awareness among people may provide numerous opportunities for market expansion.

The neurodiagnostic and monitoring devices market is segmented on the basis of product, end user, and region. Products studied in the report include magnetoencephalography (MEG), electromyography (EMG), transcranial cerebral oximeters, electroencephalogram (EEG), cerebral oximeters, and intracranial pressure monitor. On the basis of end user, the market is divided into operation theatres, hospitals, clinics, and neurophysiological laboratories. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in this market include Blackrock NeuroMed, Cadwell Laboratories, Compumedics, Delsys, Electrical Geodesic (EGI), Elmiko, LifeLines Neurodiagnostic Systems, MEG International Services, Motion Lab Systems, and Natus Medical.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
  • The report offers a quantitative analysis, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Exhaustive analysis of the neurodiagnostic and monitoring devices market by type helps in understanding the types of devices that are currently being used along with the variants that would gain prominence in the future.

 Key Market Segments

  • By Product
    • Magnetoencephalography (MEG)
    • Electromyography (EMG)
    • Transcranial Cerebral Oximeters
    • Electroencephalogram (EEG)
    • Cerebral Oximeters
    • Intracranial Pressure Monitor
  • By End User
    • Operation Theatres
    • Hospitals
    • Clinics
    • Neurophysiological Laboratories
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Natus Medical.
  • Compumedics,
  • Elmiko,
  • Motion Lab Systems,
  • LifeLines Neurodiagnostic Systems,
  • Delsys,
  • Electrical Geodesic (EGI),
  • Cadwell Laboratories,
  • MEG International Services,
  • Blackrock NeuroMed,

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Magnetoencephalography (MEG)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Electromyography (EMG)

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Transcranial Cerebral Oximeters

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Electroencephalogram (EEG)

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Cerebral Oximeters

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Intracranial Pressure Monitor

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

  • CHAPTER 5: NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Operation Theatres

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Hospitals

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Clinics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Neurophysiological Laboratories

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Neurodiagnostic And Monitoring Devices Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Neurodiagnostic And Monitoring Devices Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Neurodiagnostic And Monitoring Devices Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Neurodiagnostic And Monitoring Devices Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Neurodiagnostic And Monitoring Devices Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Neurodiagnostic And Monitoring Devices Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Neurodiagnostic And Monitoring Devices Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Neurodiagnostic And Monitoring Devices Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Neurodiagnostic And Monitoring Devices Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Neurodiagnostic And Monitoring Devices Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Neurodiagnostic And Monitoring Devices Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Neurodiagnostic And Monitoring Devices Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Neurodiagnostic And Monitoring Devices Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Neurodiagnostic And Monitoring Devices Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Neurodiagnostic And Monitoring Devices Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Neurodiagnostic And Monitoring Devices Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Neurodiagnostic And Monitoring Devices Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Neurodiagnostic And Monitoring Devices Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Neurodiagnostic And Monitoring Devices Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Neurodiagnostic And Monitoring Devices Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Neurodiagnostic And Monitoring Devices Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Neurodiagnostic And Monitoring Devices Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Neurodiagnostic And Monitoring Devices Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Neurodiagnostic And Monitoring Devices Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Neurodiagnostic And Monitoring Devices Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Blackrock NeuroMed,

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Cadwell Laboratories,

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Compumedics,

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Delsys,

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Electrical Geodesic (EGI),

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Elmiko,

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. LifeLines Neurodiagnostic Systems,

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. MEG International Services,

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Motion Lab Systems,

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Natus Medical.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR MAGNETOENCEPHALOGRAPHY (MEG), BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR ELECTROMYOGRAPHY (EMG), BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR TRANSCRANIAL CEREBRAL OXIMETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR ELECTROENCEPHALOGRAM (EEG), BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR CEREBRAL OXIMETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR INTRACRANIAL PRESSURE MONITOR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR OPERATION THEATRES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR NEUROPHYSIOLOGICAL LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA NEURODIAGNOSTIC AND MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. U.S. NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. U.S. NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. CANADA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. CANADA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE NEURODIAGNOSTIC AND MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. FRANCE NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. FRANCE NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. GERMANY NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. GERMANY NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. ITALY NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. ITALY NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. SPAIN NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. SPAIN NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. UK NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. UK NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. RUSSIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. RUSSIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. REST OF EUROPE NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. REST OF EUROPE NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC NEURODIAGNOSTIC AND MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. CHINA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. CHINA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. JAPAN NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. JAPAN NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. INDIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. INDIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. SOUTH KOREA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. SOUTH KOREA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. AUSTRALIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. AUSTRALIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. THAILAND NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. THAILAND NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. MALAYSIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. MALAYSIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. INDONESIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. INDONESIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA NEURODIAGNOSTIC AND MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. BRAZIL NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. BRAZIL NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH AFRICA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH AFRICA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SAUDI ARABIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. SAUDI ARABIA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. UAE NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. UAE NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. ARGENTINA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. ARGENTINA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. REST OF LAMEA NEURODIAGNOSTIC AND MONITORING DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. REST OF LAMEA NEURODIAGNOSTIC AND MONITORING DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. BLACKROCK NEUROMED,: KEY EXECUTIVES
  • TABLE 77. BLACKROCK NEUROMED,: COMPANY SNAPSHOT
  • TABLE 78. BLACKROCK NEUROMED,: OPERATING SEGMENTS
  • TABLE 79. BLACKROCK NEUROMED,: PRODUCT PORTFOLIO
  • TABLE 80. BLACKROCK NEUROMED,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. CADWELL LABORATORIES,: KEY EXECUTIVES
  • TABLE 82. CADWELL LABORATORIES,: COMPANY SNAPSHOT
  • TABLE 83. CADWELL LABORATORIES,: OPERATING SEGMENTS
  • TABLE 84. CADWELL LABORATORIES,: PRODUCT PORTFOLIO
  • TABLE 85. CADWELL LABORATORIES,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. COMPUMEDICS,: KEY EXECUTIVES
  • TABLE 87. COMPUMEDICS,: COMPANY SNAPSHOT
  • TABLE 88. COMPUMEDICS,: OPERATING SEGMENTS
  • TABLE 89. COMPUMEDICS,: PRODUCT PORTFOLIO
  • TABLE 90. COMPUMEDICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. DELSYS,: KEY EXECUTIVES
  • TABLE 92. DELSYS,: COMPANY SNAPSHOT
  • TABLE 93. DELSYS,: OPERATING SEGMENTS
  • TABLE 94. DELSYS,: PRODUCT PORTFOLIO
  • TABLE 95. DELSYS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. ELECTRICAL GEODESIC (EGI),: KEY EXECUTIVES
  • TABLE 97. ELECTRICAL GEODESIC (EGI),: COMPANY SNAPSHOT
  • TABLE 98. ELECTRICAL GEODESIC (EGI),: OPERATING SEGMENTS
  • TABLE 99. ELECTRICAL GEODESIC (EGI),: PRODUCT PORTFOLIO
  • TABLE 100. ELECTRICAL GEODESIC (EGI),: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. ELMIKO,: KEY EXECUTIVES
  • TABLE 102. ELMIKO,: COMPANY SNAPSHOT
  • TABLE 103. ELMIKO,: OPERATING SEGMENTS
  • TABLE 104. ELMIKO,: PRODUCT PORTFOLIO
  • TABLE 105. ELMIKO,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. LIFELINES NEURODIAGNOSTIC SYSTEMS,: KEY EXECUTIVES
  • TABLE 107. LIFELINES NEURODIAGNOSTIC SYSTEMS,: COMPANY SNAPSHOT
  • TABLE 108. LIFELINES NEURODIAGNOSTIC SYSTEMS,: OPERATING SEGMENTS
  • TABLE 109. LIFELINES NEURODIAGNOSTIC SYSTEMS,: PRODUCT PORTFOLIO
  • TABLE 110. LIFELINES NEURODIAGNOSTIC SYSTEMS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. MEG INTERNATIONAL SERVICES,: KEY EXECUTIVES
  • TABLE 112. MEG INTERNATIONAL SERVICES,: COMPANY SNAPSHOT
  • TABLE 113. MEG INTERNATIONAL SERVICES,: OPERATING SEGMENTS
  • TABLE 114. MEG INTERNATIONAL SERVICES,: PRODUCT PORTFOLIO
  • TABLE 115. MEG INTERNATIONAL SERVICES,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. MOTION LAB SYSTEMS,: KEY EXECUTIVES
  • TABLE 117. MOTION LAB SYSTEMS,: COMPANY SNAPSHOT
  • TABLE 118. MOTION LAB SYSTEMS,: OPERATING SEGMENTS
  • TABLE 119. MOTION LAB SYSTEMS,: PRODUCT PORTFOLIO
  • TABLE 120. MOTION LAB SYSTEMS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. NATUS MEDICAL.: KEY EXECUTIVES
  • TABLE 122. NATUS MEDICAL.: COMPANY SNAPSHOT
  • TABLE 123. NATUS MEDICAL.: OPERATING SEGMENTS
  • TABLE 124. NATUS MEDICAL.: PRODUCT PORTFOLIO
  • TABLE 125. NATUS MEDICAL.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEURODIAGNOSTIC AND MONITORING DEVICES MARKET
  • FIGURE 3. SEGMENTATION NEURODIAGNOSTIC AND MONITORING DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEURODIAGNOSTIC AND MONITORING DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEURODIAGNOSTIC AND MONITORING DEVICES MARKET
  • FIGURE 11. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR MAGNETOENCEPHALOGRAPHY (MEG), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR ELECTROMYOGRAPHY (EMG), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR TRANSCRANIAL CEREBRAL OXIMETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR ELECTROENCEPHALOGRAM (EEG), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR CEREBRAL OXIMETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR INTRACRANIAL PRESSURE MONITOR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 19. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR OPERATION THEATRES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET FOR NEUROPHYSIOLOGICAL LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: NEURODIAGNOSTIC AND MONITORING DEVICES MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. BLACKROCK NEUROMED,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. BLACKROCK NEUROMED,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. BLACKROCK NEUROMED,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. CADWELL LABORATORIES,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. CADWELL LABORATORIES,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. CADWELL LABORATORIES,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. COMPUMEDICS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. COMPUMEDICS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. COMPUMEDICS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. DELSYS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. DELSYS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. DELSYS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. ELECTRICAL GEODESIC (EGI),: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. ELECTRICAL GEODESIC (EGI),: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. ELECTRICAL GEODESIC (EGI),: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. ELMIKO,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. ELMIKO,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. ELMIKO,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. LIFELINES NEURODIAGNOSTIC SYSTEMS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. LIFELINES NEURODIAGNOSTIC SYSTEMS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. LIFELINES NEURODIAGNOSTIC SYSTEMS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. MEG INTERNATIONAL SERVICES,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. MEG INTERNATIONAL SERVICES,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. MEG INTERNATIONAL SERVICES,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. MOTION LAB SYSTEMS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. MOTION LAB SYSTEMS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. MOTION LAB SYSTEMS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. NATUS MEDICAL.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. NATUS MEDICAL.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. NATUS MEDICAL.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neurodiagnostic and Monitoring Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved